1.Construction of a live attenuated Salmonella strain expressing FanC protein to prevent bovine enterotoxigenic Escherichia coli and evaluation of its immunogenicity in mice.
Gayeon WON ; Hee Jung KIM ; John Hwa LEE
Korean Journal of Veterinary Research 2017;57(1):9-15
To construct a novel vaccine candidate against bovine enterotoxigenic Escherichia coli (ETEC), FanC, the major subunit of K99 fimbriae adhesion, was inserted into secretion plasmid pYA3560 containing a β-lactamase secretion system. This was then transformed into Δasd Δcrp Salmonella (S.) Typhimurium and designated as JOL950. Secretion of recombinant fanC fimbrial antigens was confirmed by immunoblot analysis. Groups of mice were inoculated with single or double doses of JOL950. Another group was used as a negative control. Compared to control mice, all immunized mice had significantly higher levels (p < 0.05) of serum immunoglobulin (Ig)G, and secretory IgA against FanC. The IgG2a and IgG1 titer assays revealed that immunization highly induced IgG2a compared to that of IgG1, indicating that T helper-1- related cell-mediated immune responses may be elicited by JOL950. The results show that both systemic and mucosal immunities against selected fimbrial antigens of bovine ETEC expressed by a live attenuated S. Typhimurium strain are prominently produced in mice immunized with JOL950 via an oral route.
Animals
;
Enterotoxigenic Escherichia coli*
;
Immunization
;
Immunoglobulin A, Secretory
;
Immunoglobulin G
;
Immunoglobulins
;
Mice*
;
Plasmids
;
Salmonella*
2.Similar Durability of Two Single Tablet Regimens, Dolutegravir/Abacavir/Lamivudine and Elvitegravir/Cobicistat/Tenofovir/Emtricitabine: Single Center Experience
Bum Sik CHIN ; Jin-Hee LEE ; Gayeon KIM
Journal of Korean Medical Science 2020;35(29):e235-
Integrase inhibitor is uniquely available as single tablet regimen (STR) in Korea. In this study, the durability until 96 weeks was compared between dolutegravir/abacavir/lamivudine (D/A/L) and elvitegravir/cobicistat/tenofovir/emtricitabine (E/T/E) in treatment naïve human immunodeficiency virus 1 (HIV-1) infected individuals. From 2014 to 2017, 153 and 234 subjects started D/A/L and E/T/E, respectively. During 96 weeks, 73 discontinued initial STR and the reason of discontinuation was typable in 44. The frequency of drug adverse event related discontinuation (AEDC) was higher in D/A/L (13.1% vs. 6.4%, P = 0.023) while most non-AE related discontinuations occurred in E/T/E (8/9), such as drug-drug interaction, meal requirement and virologic failure. AEDC occurred usually within 24 weeks (20/35) and D/A/L to E/T/E AEDC incidence rate ratio was 3.71 (95% confidence interval, 1.36–10.10) in this period. Regarding the durability, D/A/L and E/T/E revealed no significant difference at week 96 (P = 0.138) while durability of D/A/L was worse in the aspect of AEDC (P = 0.013).
3.Adverse Reactions After Intradermal Vaccination With JYNNEOS for Mpox in Korea
So Yun LIM ; Yu Mi JUNG ; Yeonjae KIM ; Gayeon KIM ; Jaehyun JEON ; BumSik CHIN ; Min-Kyung KIM
Journal of Korean Medical Science 2024;39(8):e100-
In response to the Mpox domestic epidemic, South Korea initiated a nationwide vaccination program in May 2023, administering a 0.1 mL intradermal dose of JYNNEOS (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to a high-risk group. To investigate the adverse reactions after intradermal JYNNEOS vaccination, an anonymous online survey was conducted at the National Medical Center from May 22 to July 31, 2023. Overall, 142 individuals responded. Over 80% of the respondents reported local reactions of predominantly mild severity. The predominant local reactions were pruritus, redness, and swelling; their incidence rates after the first dose were 66.2%, 48.1%, and 49.4%, respectively; the corresponding rates after the second dose were 69.2%, 60.6%, and 53.8%. Fewer respondents reported systemic symptoms. The most common systemic symptom was fatigue, the incidence rates of which after the first and second doses were 37.7% and 24.6%, respectively. Overall, the intradermally administered JYNNEOS vaccine appeared well tolerated.
4.Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study.
Yeonjae KIM ; Bum Sik CHIN ; Gayeon KIM ; Hyoung Shik SHIN
Journal of Korean Medical Science 2018;33(25):e173-
The present study investigated prevalence of integrase strand transfer inhibitors (INSTI) resistance mutations in HIV-1-infected antiretroviral therapy (ART)-naïve patients in Korea. From 106 plasma samples, amplification and sequencing of integrase genes was performed, and major or minor mutations were calculated by the Stanford HIV drug resistance mutation interpretation algorithm. No major INSTI resistance mutations were found, and 14 minor mutations were detected in 13 (12.3%) patients. The present data support the recommendation that routine testing for INSTI resistance mutations before starting ART is not necessary.
Drug Resistance
;
HIV
;
Humans
;
Integrases*
;
Korea*
;
Observational Study*
;
Plasma
;
Prevalence
;
Prospective Studies*
5.Observation of an extracted premolar 2.5 years after mineral trioxide aggregate apexification using micro-computed tomography
Gayeon LEE ; Chooryung CHUNG ; Sunil KIM ; Su-Jung SHIN
Restorative Dentistry & Endodontics 2020;45(2):e4-
Although numerous studies have been conducted on apexification using mineral trioxide aggregate (MTA), direct observation of extracted human teeth after the procedure has been rarely reported. This case report describes a mandibular premolar treated 2.5 years ago and extracted recently for orthodontic treatment. The tubercle of the right mandibular premolar of a 12-year-old boy with dens evaginatus was fractured and the pulp was exposed. The tooth was diagnosed with pulp necrosis and asymptomatic periapical abscess. During the first visit, copious irrigation was performed with 2.5% sodium hypochlorite. Calcium hydroxide paste was placed as an intracanal medicament. The sinus tract had disappeared at the second visit after 3 weeks. MTA was applied on to the bleeding point as a 4-mm-thick layer, followed by a 3-mm-thick gutta-percha filling and resin core build-up. After 2.5 years, the tooth and three other premolars were extracted for orthodontic treatment. The right and left mandibular premolars were scanned with micro-computed tomography to determine the root shape and canal anatomy. Irregular root growth was observed and the root outline of the right mandibular premolar differed from that of the contralateral tooth. Apexification with MTA leads to the formation of roots with irregular morphology, without any pulpal space.
6.Alternating Linezolid-Vancomycin Therapy for Persistent Endovascular Methicillin-resistant Staphylococcus aureus Infection: A Case Report.
Nak Hyun KIM ; Moonsuk KIM ; Eun Sun JANG ; Yu Min KANG ; Gayeon KIM ; Hee Chang JANG ; Wan Beom PARK ; Eui Chong KIM ; Nam Joong KIM ; Myoung don OH
Infection and Chemotherapy 2009;41(6):371-374
Persistent Staphylococcus aureus bacteremia is frequently defined as bacteremia persisting for > or =7 days despite proper antibiotic therapy. Its treatment includes removal of all infection foci and proper antibiotic therapy. Vancomycin remains the antibiotic of choice in MRSA bacteremia. Alternative agents, linezolid or daptomycin, are available, but a consensus regarding management of persistent MRSA bacteremia on vancomycin failure is still lacking. We report a case of a 60-year-old male who received thoracoabdominal aorta replacement operation due to dissecting aneurysm of the ascending and descending aorta. Surgical site infection and bacteremia caused by MRSA occured, and wound debridement operations were performed. The patient was treated with vancomycin in therapeutic doses but MRSA bacteremia persisted for 168 days in a row. Although the inserted aortic graft was the most probable source of persistent bacteremia, surgical removal was impossible. Linezolid was administered as an alternative antibiotic but had to be discontinued from time to time due to thrombocytopenia induced by this agent. In the end, MRSA bacteremia was successfully managed by alternating vancomycin-linezolid therapy.
Acetamides
;
Aneurysm, Dissecting
;
Aorta
;
Aorta, Thoracic
;
Bacteremia
;
Consensus
;
Daptomycin
;
Debridement
;
Humans
;
Linezolid
;
Male
;
Methicillin Resistance
;
Methicillin-Resistant Staphylococcus aureus
;
Middle Aged
;
Oxazolidinones
;
Staphylococcus aureus
;
Thrombocytopenia
;
Transplants
;
Treatment Failure
;
Vancomycin
7.Alternating Linezolid-Vancomycin Therapy for Persistent Endovascular Methicillin-resistant Staphylococcus aureus Infection: A Case Report.
Nak Hyun KIM ; Moonsuk KIM ; Eun Sun JANG ; Yu Min KANG ; Gayeon KIM ; Hee Chang JANG ; Wan Beom PARK ; Eui Chong KIM ; Nam Joong KIM ; Myoung don OH
Infection and Chemotherapy 2009;41(6):371-374
Persistent Staphylococcus aureus bacteremia is frequently defined as bacteremia persisting for > or =7 days despite proper antibiotic therapy. Its treatment includes removal of all infection foci and proper antibiotic therapy. Vancomycin remains the antibiotic of choice in MRSA bacteremia. Alternative agents, linezolid or daptomycin, are available, but a consensus regarding management of persistent MRSA bacteremia on vancomycin failure is still lacking. We report a case of a 60-year-old male who received thoracoabdominal aorta replacement operation due to dissecting aneurysm of the ascending and descending aorta. Surgical site infection and bacteremia caused by MRSA occured, and wound debridement operations were performed. The patient was treated with vancomycin in therapeutic doses but MRSA bacteremia persisted for 168 days in a row. Although the inserted aortic graft was the most probable source of persistent bacteremia, surgical removal was impossible. Linezolid was administered as an alternative antibiotic but had to be discontinued from time to time due to thrombocytopenia induced by this agent. In the end, MRSA bacteremia was successfully managed by alternating vancomycin-linezolid therapy.
Acetamides
;
Aneurysm, Dissecting
;
Aorta
;
Aorta, Thoracic
;
Bacteremia
;
Consensus
;
Daptomycin
;
Debridement
;
Humans
;
Linezolid
;
Male
;
Methicillin Resistance
;
Methicillin-Resistant Staphylococcus aureus
;
Middle Aged
;
Oxazolidinones
;
Staphylococcus aureus
;
Thrombocytopenia
;
Transplants
;
Treatment Failure
;
Vancomycin
8.A Case of Infectious Spondylodiscitis due to Parvimonas Micra.
Yu Min KANG ; Gayeon KIM ; Young Hee JUNG ; Chi Heon KIM ; Eui Chong KIM ; Nam Joong KIM ; Myoung Don OH
Korean Journal of Medicine 2012;82(5):632-636
Parvimonas micra is frequently associated with periodontal disease as well as respiratory, gastrointestinal, and female genitourinary tract infections, but only rarely has it been reported as a pathogenic agent of infectious spondylodiscitis. We describe the case of a 38-year-old woman with spondylodiscitis caused by P. micra. P. micra was cultured from the patient's blood and vertebral tissue. This case was treated with vertebral corpectomy followed by intravenous ampicillin-sulbactam for four weeks. Her symptoms and vital signs improved, and elevated inflammatory markers were normalized after treatment.
Adult
;
Ampicillin
;
Bacteria, Anaerobic
;
Discitis
;
Female
;
Humans
;
Periodontal Diseases
;
Spondylitis
;
Sulbactam
;
Vital Signs
9.A Case of Infectious Spondylodiscitis due to Parvimonas Micra
Yu Min KANG ; Gayeon KIM ; Young Hee JUNG ; Chi Heon KIM ; Eui Chong KIM ; Nam Joong KIM ; Myoung Don OH
Korean Journal of Medicine 2012;82(5):632-636
Parvimonas micra is frequently associated with periodontal disease as well as respiratory, gastrointestinal, and female genitourinary tract infections, but only rarely has it been reported as a pathogenic agent of infectious spondylodiscitis. We describe the case of a 38-year-old woman with spondylodiscitis caused by P. micra. P. micra was cultured from the patient's blood and vertebral tissue. This case was treated with vertebral corpectomy followed by intravenous ampicillin-sulbactam for four weeks. Her symptoms and vital signs improved, and elevated inflammatory markers were normalized after treatment.
Adult
;
Ampicillin
;
Bacteria, Anaerobic
;
Discitis
;
Female
;
Humans
;
Periodontal Diseases
;
Spondylitis
;
Sulbactam
;
Vital Signs
10.Mixed Infection with Plasmodium falciparum and Plasmodium ovale in a Returned Traveller: the First Case in Korea.
Gayeon KIM ; Hyo Lim HONG ; So Yeon KIM ; Hye Ryun LEE ; Dong Geun KIM ; Seungman PARK ; Hyoung Shik SHIN ; Bum Sik CHIN ; YeonJae KIM
Journal of Korean Medical Science 2019;34(3):e23-
Mixed-species malaria infections are often unrecognized or underestimated. We hereby report the first described case of mixed infection with Plasmodium falciparum and Plasmodium ovale malaria in a returned traveller in Korea. In August 2016, a 25-year-old returned traveller from Cameroon and Democratic Republic of Congo presented with fever. He was diagnosed as P. falciparum malaria and successfully treated with artesunate. And 5 weeks after the completion of treatment, he presented with fever and diagnosed as P. ovale infection. P. ovale infection is a rare cause of malaria and often shows delayed presentation due to its dormant liver stage as hypnozoites. At re-presentation, the immunochromatographic test and microscopic examinations of our patient did not reveal P. ovale, which was only detected via polymerase chain reaction (PCR) assay. This case highlights the importance of considering malaria infection even in persons who have previously received malaria treatment. It also shows the usefulness of PCR testing for diagnosing P. ovale infections, which often present with a low level of parasitaemia.
Adult
;
Cameroon
;
Coinfection*
;
Congo
;
Fever
;
Humans
;
Korea*
;
Liver
;
Malaria
;
Plasmodium falciparum*
;
Plasmodium ovale*
;
Plasmodium*
;
Polymerase Chain Reaction